◆BLACKSPECTER AI Chat öffnen →

BlackSpecter›Aktien›EDIT

EDIT (EDIT)

Kennzahlen

Marktkapitalisierung

n/a

KGV (TTM)

n/a

Umsatz (TTM)

n/a

EBITDA

n/a

Dividendenrendite

n/a

52W Hoch

n/a

52W Tief

n/a

Beta

n/a

EPS (TTM)

n/a

Forward KGV

n/a

PEG Ratio

n/a

Short-Quote

n/a

Analysten-Ratings

Keine Analysten-Daten verfügbar

Earnings

Keine Earnings-Daten verfügbar

Aktuelle News

Zacks·vor 5 Tagen

4 Gene-Editing Biotech Stocks Worth Watching for Long-Term Gains

24/7 Wall St.·vor 9 Tagen

Moderna’s Newfound War Chest Opens Door for 4 Strategic Acquisition Targets

MT Newswires·vor 11 Tagen

Ladenburg Thalmann Initiates Editas Medicine at Buy With $6 Price Target

Zacks·vor 19 Tagen

Is Editas Medicine (EDIT) Outperforming Other Medical Stocks This Year?

Zacks·vor 23 Tagen

EDIT Q2 Earnings Beat Estimates, Revenues Rise, Pipeline in Focus

Zacks·vor 24 Tagen

Editas Medicine (EDIT) Reports Q2 Loss, Beats Revenue Estimates

Frag BlackSpecter AI über EDIT

Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.

Ist EDIT kaufenswert?EDIT Earnings Analyse EDIT Bewertung

AI Chat öffnen →